These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36033764)

  • 1. Quantifying the primary and secondary effects of antimicrobial resistance on surgery patients: Methods and data sources for empirical estimation in England.
    Naylor NR; Evans S; Pouwels KB; Troughton R; Lamagni T; Muller-Pebody B; Knight GM; Atun R; Robotham JV
    Front Public Health; 2022; 10():803943. PubMed ID: 36033764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated one-day surveillance of antimicrobial use, antimicrobial consumption, antimicrobial resistance, healthcare-associated infection, and antimicrobial resistance burden among hospitalized patients in Thailand.
    Thamlikitkul V; Rattanaumpawan P; Sirijatuphat R; Wangchinda W
    J Infect; 2020 Jul; 81(1):98-106. PubMed ID: 32360884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
    Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
    Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving feedback of surveillance data on antimicrobial consumption, resistance and stewardship in England: putting the data at your Fingertips.
    Johnson AP; Muller-Pebody B; Budd E; Ashiru-Oredope D; Ladenheim D; Hain D; Hope R; Bhattacharya A; Elgohari S; Guy R; Henderson K; Puleston R; Rooney G; Thelwall S; Wellington E; Lamagni T; Hopkins S
    J Antimicrob Chemother; 2017 Apr; 72(4):953-956. PubMed ID: 27999049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics.
    Harding-Esch EM; Huntington SE; Harvey MJ; Weston G; Broad CE; Adams EJ; Sadiq ST
    Euro Surveill; 2020 Oct; 25(43):. PubMed ID: 33124553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a Modeling Framework for Quantifying the Health and Cost Implications of Antibiotic Resistance for Surgical Procedures.
    Davies H; Russell J; Varghese A; Holmes H; Soares MO; Woods B; Puig-Peiro R; Evans S; Tierney R; Mealing S; Sculpher M; Robotham JV
    MDM Policy Pract; 2023; 8(1):23814683231152885. PubMed ID: 36755742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model.
    Gordon J; Darlington O; McEwan P; Lumley M; Taie A; Hicks M; Charbonneau C; Blake A; Hawkins N; Goldenberg S; Otter J; Wilcox M
    Pharmacoeconomics; 2020 Aug; 38(8):857-869. PubMed ID: 32249396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings.
    Okeke IN; Feasey N; Parkhill J; Turner P; Limmathurotsakul D; Georgiou P; Holmes A; Peacock SJ
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33268385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-level mathematical modeling of antimicrobial resistance: a systematic review.
    Niewiadomska AM; Jayabalasingham B; Seidman JC; Willem L; Grenfell B; Spiro D; Viboud C
    BMC Med; 2019 Apr; 17(1):81. PubMed ID: 31014341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease burden, associated mortality and economic impact of antimicrobial resistant infections in Australia.
    Wozniak TM; Dyda A; Merlo G; Hall L
    Lancet Reg Health West Pac; 2022 Oct; 27():100521. PubMed ID: 35832237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AmWeb: a novel interactive web tool for antimicrobial resistance surveillance, applicable to both community and hospital patients.
    Ironmonger D; Edeghere O; Gossain S; Bains A; Hawkey PM
    J Antimicrob Chemother; 2013 Oct; 68(10):2406-13. PubMed ID: 23687187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.
    Saleem Z; Godman B; Azhar F; Kalungia AC; Fadare J; Opanga S; Markovic-Pekovic V; Hoxha I; Saeed A; Al-Gethamy M; Haseeb A; Salman M; Khan AA; Nadeem MU; Rehman IU; Qamar MU; Amir A; Ikram A; Hassali MA
    Expert Rev Anti Infect Ther; 2022 Jan; 20(1):71-93. PubMed ID: 34038294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections.
    Whittle E; Yonkus JA; Jeraldo P; Alva-Ruiz R; Nelson H; Kendrick ML; Grys TE; Patel R; Truty MJ; Chia N
    mSphere; 2022 Feb; 7(1):e0096421. PubMed ID: 35171692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
    Sulis G; Sayood S; Gandra S
    Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting up laboratory-based antimicrobial resistance surveillance in low- and middle-income countries: lessons learned from Georgia.
    Malania L; Wagenaar I; Karatuna O; Tambic Andrasevic A; Tsereteli D; Baidauri M; Imnadze P; Nahrgang S; Ruesen C
    Clin Microbiol Infect; 2021 Oct; 27(10):1409-1413. PubMed ID: 34044149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present and Future Surveillance of Antimicrobial Resistance in Animals: Principles and Practices.
    Simjee S; McDermott P; Trott DJ; Chuanchuen R
    Microbiol Spectr; 2018 Jul; 6(4):. PubMed ID: 30003869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination to Reduce Antimicrobial Resistance Burden-Data Gaps and Future Research.
    Tadesse BT; Keddy KH; Rickett NY; Zhusupbekova A; Poudyal N; Lawley T; Osman M; Dougan G; Kim JH; Lee JS; Jeon HJ; Marks F
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S597-S607. PubMed ID: 38118013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans.
    Schrijver R; Stijntjes M; Rodríguez-Baño J; Tacconelli E; Babu Rajendran N; Voss A
    Clin Microbiol Infect; 2018 Jun; 24(6):577-590. PubMed ID: 28970159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.